CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 443 filers reported holding CRISPR THERAPEUTICS AG in Q4 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90 | -43.8% | 2,000 | -30.1% | 0.01% | -59.1% |
| Q2 2023 | $160 | +416.1% | 2,860 | +308.6% | 0.02% | +633.3% |
| Q1 2023 | $31 | – | 700 | -96.2% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 18,600 | -57.2% | 0.00% | -100.0% |
| Q3 2022 | $1,306,000 | -10.4% | 43,453 | -28.5% | 0.09% | -12.7% |
| Q2 2022 | $1,457,000 | -41.8% | 60,800 | -16.8% | 0.10% | -22.7% |
| Q1 2022 | $2,505,000 | -16.6% | 73,068 | -32.7% | 0.13% | +4.8% |
| Q4 2021 | $3,003,000 | +32.6% | 108,538 | +115.8% | 0.13% | +23.5% |
| Q3 2021 | $2,265,000 | -22.1% | 50,300 | +1.7% | 0.10% | -25.0% |
| Q2 2021 | $2,909,000 | +39.7% | 49,480 | +0.8% | 0.14% | +32.0% |
| Q1 2021 | $2,082,000 | -30.6% | 49,100 | +35.0% | 0.10% | -28.0% |
| Q4 2020 | $3,000,000 | +3847.4% | 36,360 | +690.4% | 0.14% | +2760.0% |
| Q3 2020 | $76,000 | -44.1% | 4,600 | -68.9% | 0.01% | -44.4% |
| Q2 2020 | $136,000 | +240.0% | 14,800 | +492.0% | 0.01% | +350.0% |
| Q1 2020 | $40,000 | -69.9% | 2,500 | -13.8% | 0.00% | -75.0% |
| Q4 2019 | $133,000 | +2560.0% | 2,900 | +480.0% | 0.01% | – |
| Q3 2019 | $5,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | -28.6% | 500 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $7,000 | -22.2% | 500 | -50.0% | 0.00% | 0.0% |
| Q4 2018 | $9,000 | -79.5% | 1,000 | -86.1% | 0.00% | -66.7% |
| Q3 2018 | $44,000 | -70.9% | 7,200 | -61.7% | 0.00% | -75.0% |
| Q2 2018 | $151,000 | -54.4% | 18,800 | +10.0% | 0.01% | -57.1% |
| Q1 2018 | $331,000 | +2658.3% | 17,097 | +248.9% | 0.03% | – |
| Q4 2017 | $12,000 | -70.7% | 4,900 | -86.5% | 0.00% | -100.0% |
| Q3 2017 | $41,000 | +485.7% | 36,300 | +1989.8% | 0.00% | – |
| Q2 2017 | $7,000 | – | 1,737 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |